I-Tek

I-Tek Medical is a specialized medical technology company focused on the development of transcatheter valve replacement and repair solutions for structural heart diseases. Based in Suzhou, China, the company develops a comprehensive portfolio of minimally invasive devices, including systems for transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement (TMVR), and transcatheter tricuspid valve replacement (TTVR). I-Tek Medical is led by experienced professionals from the interventional cardiology industry and has secured significant venture capital from prominent investors like Sequoia China and Qiming Venture Partners. The company's products aim to address the unmet clinical needs of patients with severe valvular heart disease through advanced engineering and clinical research. Its flagship I-TAVI system is currently in late-stage clinical trials, positioning the company as a key player in the emerging Chinese structural heart market.